Lead Product(s) : Dinoprostone
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Labor Induction After Failed Induction With Dinoprostone.
Details : Dinoprostone is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 22, 2020
Lead Product(s) : Dinoprostone
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Dinoprostone
Therapeutic Area : Undisclosed
Study Phase : Phase III
Sponsor : Ferring Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
A Trial of Cervidil for Outpatient Pre-induction of Cervical Ripening
Details : Dinoprostone is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 16, 2019
Lead Product(s) : Dinoprostone
Therapeutic Area : Undisclosed
Highest Development Status : Phase III
Sponsor : Ferring Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Dinoprostone
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Undisclosed
Sponsor : Ferring Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Foley Catheter Compared to the Foley Catheter Alone for Cervical Ripening
Details : Prostaglandin E2 is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Cervical Ripening.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 12, 2017
Lead Product(s) : Dinoprostone
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Undisclosed
Sponsor : Ferring Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Dinoprostone
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Dinoprostone is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Cervical Ripening.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 01, 2017
Lead Product(s) : Dinoprostone
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Dinoprostone
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Dinoprostone is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Cervical Ripening.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 01, 2017
Lead Product(s) : Dinoprostone
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Dinoprostone
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Labor Induction With Dinoprostone in Oppose to Cervical Ripening Balloon as a Factor of BMI.
Details : Dinoprostone is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Labor, Induced.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 26, 2017
Lead Product(s) : Dinoprostone
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Dinoprostone
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Dinoprostone is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Medical Induction of Labor.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 07, 2016
Lead Product(s) : Dinoprostone
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Dinoprostone
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Dinoprostone is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Obesity.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 14, 2013
Lead Product(s) : Dinoprostone
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Dinoprostone
Therapeutic Area : Undisclosed
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Dinoprostone is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 27, 2010
Lead Product(s) : Dinoprostone
Therapeutic Area : Undisclosed
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
